Targeted Therapies in Oncology

October 2026
Volume: 15
Issue: 10

September 2026
Volume: 15
Issue: 9

August 2026
Volume: 15
Issue: 8

July 2026
Volume: 15
Issue: 7

June 2026
Volume: 15
Issue: 6

May 2026
Volume: 15
Issue: 5

April 2026
Volume: 15
Issue: 4

March 2026
Volume: 15
Issue: 3

February 2026
Volume: 15
Issue: 2

January 2026
Volume: 15
Issue: 1

December II 2025
Volume: 14
Issue: 16

December I 2025
Volume: 14
Issue: 15

November 2025
Volume: 14
Issue: 14

October 2025
Volume: 14
Issue: 13

September II 2025
Volume: 14
Issue: 12

September I 2025
Volume: 14
Issue: 11

August 2025
Volume: 14
Issue: 10

July 2025
Volume: 14
Issue: 9

June II 2025
Volume: 14
Issue: 8

June I 2025
Volume: 14
Issue: 7

May I 2025
Volume: 14
Issue: 6

April I 2025
Volume: 14
Issue: 5

March II 2025
Volume: 14
Issue: 4

March I 2025
Volume: 14
Issue: 3

February I, 2025
Volume: 14
Issue: 2

January I 2025
Volume: 14
Issue: 1

December II, 2024
Volume: 13
Issue: 16

December I, 2024
Volume: 13
Issue: 15

November I, 2024
Volume: 13
Issue: 14

October I, 2024
Volume: 13
Issue: 13
Advertisement
Advertisement
Trending on Targeted Onc
1
Galinpepimut-S Improves Overall Survival in Phase 3 REGAL Trial in AML
2
FDA Approves Neladalkib for Previously Treated Advanced ALK-Positive NSCLC
3
FDA Fast Tracks Elticertinib for Previously Treated EGFR Exon 20 NSCLC
4
Oncologists Weigh Age and Drug Interactions in mHSPC Treatment Selection
5
